Literature DB >> 1544669

Pulmonary vascular lesions in the adult respiratory distress syndrome caused by inhalation of zinc chloride smoke: a morphometric study.

S Homma1, R Jones, J Qvist, W M Zapol, L Reid.   

Abstract

Two soldiers were fatally injured by accidental inhalation of zinc chloride (ZnCl2) from a smoke bomb. Although exposed to a relatively short but high smoke concentration, acute injury was minor and for 10 days the patients were clinically satisfactory. Unexpectedly, both then rapidly developed features typical of severe adult respiratory distress syndrome with pulmonary hypertension. Intubation and mechanical ventilation were instigated on day 15 (patient no. 1) and day 12 (patient no. 2) after the inhalation, but death followed at days 25 and 32, respectively. Lung vascular injury was assessed by angiography and morphometric techniques. The lungs showed extensive interstitial and intra-alveolar space fibrosis. Vessels showed a significant lumen reduction by contracture (that is, reduction in vessel external diameter) affecting preacinar and intraacinar arterial and venous segments, the extent of injury suggesting that hexite causes more severe venous injury than seen in other types of adult respiratory distress syndrome. In microvessels there was obliteration and widespread occlusion by endothelial cell proliferation and clot. No evidence of infection was identified during life or at autopsy. It is unclear whether the long lag time was due to the fact that the infection was not a complicating event or because steroids, administered prophylactically, had sufficed to delay, but not to prevent, the amplification of injury that seems responsible for the adult respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544669     DOI: 10.1016/0046-8177(92)90010-z

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

Review 1.  Regulators of endothelial and epithelial barrier integrity and function in acute lung injury.

Authors:  Rudolf Lucas; Alexander D Verin; Stephen M Black; John D Catravas
Journal:  Biochem Pharmacol       Date:  2009-02-03       Impact factor: 5.858

2.  Pulmonary function test findings in patients with acute inhalation injury caused by smoke bombs.

Authors:  Lu Cao; Xin-Gang Zhang; Jian-Guo Wang; Han-Bin Wang; Yi-Bing Chen; Da-Hui Zhao; Wen-Fang Shi; Li-Xin Xie
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 3.  Nitric oxide and zinc homeostasis in acute lung injury.

Authors:  Claudette M St Croix; Karanee Leelavaninchkul; Simon C Watkins; Valerian E Kagan; Bruce R Pitt
Journal:  Proc Am Thorac Soc       Date:  2005

Review 4.  The essential toxin: impact of zinc on human health.

Authors:  Laura M Plum; Lothar Rink; Hajo Haase
Journal:  Int J Environ Res Public Health       Date:  2010-03-26       Impact factor: 3.390

5.  Zinc Chloride Smoke Inhalation Induced Severe Acute Respiratory Distress Syndrome: First Survival in the United States with Extended Duration (Five Weeks) Therapy with High Dose Corticosteroids in Combination with Lung Protective Ventilation.

Authors:  Hafiz Mahboob; Robert Richeson Iii; Robert McCain
Journal:  Case Rep Crit Care       Date:  2017-07-26

6.  Human amnion-derived mesenchymal stem cells alleviate lung injury induced by white smoke inhalation in rats.

Authors:  Pei Cui; Haiming Xin; Yongming Yao; Shichu Xiao; Feng Zhu; Zhenyu Gong; Zhiping Tang; Qiu Zhan; Wei Qin; Yanhua Lai; Xiaohui Li; Yalin Tong; Zhaofan Xia
Journal:  Stem Cell Res Ther       Date:  2018-04-12       Impact factor: 6.832

7.  Serum zinc level is associated with liver dysfunction caused by white smoke inhalation.

Authors:  Fei Xie; Lixin Xie
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-03-07

8.  Inhalation lung injury induced by smoke bombs in children: CT manifestations, dynamic evolution features and quantitative analysis.

Authors:  Yaqiong Ma; Shikui Zhang; Lianping Zhao; Xing Zhou; Zeqing Mao; Huaxin Xu; Xiaorui Ru; Gang Huang
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.